US, Liberia start 1st formal test of ZMapp Ebola virus drug

February 27, 2015 5:24 PM

14 0

BETHESDA, Md. — The U.S. and Liberian governments are starting the first formal patient testing of an experimental Ebola virus treatment that’s been used on an emergency basis.

The drug, ZMapp, contains three genetically engineered proteins designed to home on a target on the surface of the deadly virus to stop the disease’s progression. ZMapp, developed by San Diego-based Mapp Pharmaceuticals Inc., is “grown” in tobacco plants engineered to make large quantities of the vi...

Also read: Experimental Ebola Treatment May Be Deployed to Congo

Read more

To category page